Merck & Company, Inc. News Headlines

MRK 
$59.66
*  
0.28
0.47%
Get MRK Alerts
*Delayed - data as of Nov. 21, 2014  -  Find a broker to begin trading MRK now
Exchange: NYSE
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By
Ligand Earns Milestone Payment on EU Approval of Noxafil - Analyst Blog
10/2/2014 12:00:00 PM - Zacks.com


EUROPE MARKETS: European Stocks Flop As ECB's Draghi Talks Stimulus
10/2/2014 10:42:00 AM - Dow Jones Business News


EUROPE MARKETS: European Stocks Fall As ECB's Draghi Talks Stimulus
10/2/2014 9:55:00 AM - Dow Jones Business News


Bayer Sells $7 Billion Bond
10/2/2014 3:35:00 AM - Dow Jones Business News


Bayer Unveils Jumbo Bond Issuance With A Volume Of $7 Bln Through US Unit
10/2/2014 2:40:00 AM - RTT News


Esperion Reports Favorable Cholesterol Drug Data
10/1/2014 5:55:00 PM - Dow Jones Business News


Esperion Reports Favorable Cholesterol Drug Data -- Update
10/1/2014 5:42:00 PM - Dow Jones Business News


Bristol-Myers' Opdivo under Review in EU for Lung Cancer - Analyst Blog
10/1/2014 4:00:00 PM - Zacks.com


Merck Completes Sale Of Consumer Care Business To Bayer
10/1/2014 11:43:00 AM - RTT News


Noteworthy ETF Inflows: HDV, T, VZ, MRK
10/1/2014 10:30:58 AM - BNK Invest


Johnson & Johnson Is The Most Attractive Mega-Cap Pharma Stock For Income Investors
9/30/2014 11:27:00 AM - Seeking Alpha


Big News for These 5 Stocks From ESMO
9/30/2014 8:05:02 AM - Motley Fool


Bristol-Myers' Opdivo Under Review in US, EU for Cancer Treatment - Analyst Blog
9/29/2014 5:50:00 PM - Zacks.com


Doctor Group Backs Implantable Devices to Prevent Teen Pregnancies
9/29/2014 5:41:00 PM - Dow Jones Business News


Why Endocyte, Inc. Stock Briefly Spiked Higher
9/29/2014 12:34:11 PM - Motley Fool


Sector Update: Health-Care Shares Sink in Pre-Market Trade
9/29/2014 7:39:13 AM - MT Newswires


Sector Update: Health Care
9/29/2014 7:38:27 AM - MT Newswires


Merck: KEYTRUDA Achieves 24% Response Rate In PD-L1 Positive Urothelial Cancer
9/29/2014 5:13:00 AM - RTT News


Merck: KEYTRUDA Achieves 24% Response Rate In PD-L1 Positive Urothelial Cancer
9/29/2014 5:13:00 AM - RTT News


Merck Reports Results Of KEYTRUDA In Patients With Advanced Stomach Cancer
9/28/2014 7:13:00 AM - RTT News


'Tax Inversions' Are Tip Of An Iceberg That Already Cost The U.S. Treasury Hundreds Of Billions
9/28/2014 2:50:00 AM - Seeking Alpha


High Blood Pressure Is Most Prevalent in These 5 States
9/27/2014 11:34:02 AM - Motley Fool


Update: Ligand Augments Captisol Platform
9/26/2014 1:35:00 PM - Seeking Alpha


Dow Movers: MRK, NKE
9/26/2014 11:06:31 AM - BNK Invest


Pre-Market Most Active for Sep 26, 2014 : BBRY, MU, PFE, GE, BP, AAPL, MSFT, INTC, QQQ, JNS, NKE, MRK
9/26/2014 7:39:55 AM - NASDAQ.com News